Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival

    Research output: Contribution to journalLetterpeer-review

  3. Protein phosphatase, Mg2+/Mn2+-dependent 1D (PPM1D) mutations in haematological cancer

    Research output: Contribution to journalReviewpeer-review

  1. Factors associated with melanoma-related limb lymphoedema

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Peripheral nerve block anaesthesia and postoperative pain in acute ankle fracture surgery: the AnAnkle randomised trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Association between women's age and stage, morphology, and implantation of the competent blastocyst: a multicenter cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In 2019 the UK Myeloma Research Alliance introduced the Myeloma Risk Profile (MRP) for prediction of outcome in patients with newly diagnosed multiple myeloma (MM), ineligible for autologous stem cell transplantation. To validate the MRP in a population-based setting we performed a study of the entire cohort of transplant ineligible MM patients above 65 years in the Danish National MM Registry. Our data confirmed the value of the MRP. In a cohort of 1,377 patients, the MRP score separated patients into three distinct risk-groups with an observed hazard ratio of 2.91 for early death in high-risk versus low-risk patients.

Original languageEnglish
JournalBritish Journal of Haematology
Volume193
Issue number1
Pages (from-to)119-124
Number of pages6
ISSN0007-1048
DOIs
Publication statusPublished - Apr 2021

    Research areas

  • Myeloma Risk Profile, geriatric, multiple myeloma, prognosis, survival

ID: 62109857